Clinical observation on the effect of carnitine pharceutics on acute coronary syndrome

Objective To observe the effects on OFR activity of using complex pharmaceutics containing carnitine and pecorino (CP) on the ACS patients. Methods: 40 in-patients with ACS is were divided into two groups randomly, the CP therapy group ( group A, 20 cases) and the WM therapy group (group B,20 cases). Twenty healthy blood donors were served as controls.In group A is given CP 10 ml ,bid p.o. for 30 days, and other administrations were the same as that of group B which used routine WM therapy. Results In two groups, TG,CHO,LDL-C after therapy were significantly lower than that before; HDL-C was significant higher (P0.01).There was significant difference between group A and group B(P0.01).In group B after therapy angina and complications decreased significantly(P 0.05). Conclusion CP could alleviate the injury of OFR and had protective function on injury myocardium in ACS patients.